• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于提高非诺贝特溶解速率的固体自乳化药物递送系统(S-SEDDS)

Solid self-emulsifying drug delivery system (S-SEDDS) for improved dissolution rate of fenofibrate.

作者信息

Kanaujia Parijat, Ng Wai Kiong, Tan Reginald B H

机构信息

Institute of Chemical and Engineering Sciences , Jurong Island , Singapore .

出版信息

J Microencapsul. 2014;31(3):293-8. doi: 10.3109/02652048.2013.843601. Epub 2013 Oct 24.

DOI:10.3109/02652048.2013.843601
PMID:24156747
Abstract

PURPOSE

The aim of this work was to develop and characterise S-SEDDS containing fenofibrate (FF) for dissolution enhancement.

METHODS

The self-emulsifying pre-concentrate was prepared by using different proportion of Labrafac WL1349 as oily phase, Cremophor EL as surfactants and Gelucire 44/14 as co-surfactant. The prepared pre-concentrate was solidified with PEG 6000. For comparison, formulations containing TPGS as surfactant and solidifier were prepared and studied.

RESULTS

The cremophor/PEG and TPGS based S-SEDDS formulations containing 10 and 15% w/w FF when dispersed in water, formed nanoemulsion with a size range of 150-200 nm. FF was present in the crystalline state in the formulations. The formulations containing 10% w/w FF showed 90-100% dissolution in 60 min whereas the untreated FF showed only 2-4% dissolution.

CONCLUSION

A novel S-SEDDS was developed for FF using cremophor/PEG and TPGS. The dissolution of FF was enhanced by approximately 20-fold in SGF pH 1.2.

摘要

目的

本研究旨在开发并表征含非诺贝特(FF)的自乳化药物递送系统(S-SEDDS)以提高其溶出度。

方法

以不同比例的Labrafac WL1349为油相、聚氧乙烯蓖麻油(Cremophor EL)为表面活性剂、Gelucire 44/14为助表面活性剂制备自乳化预浓缩物。将制备的预浓缩物用聚乙二醇6000固化。为作比较,制备并研究了含生育酚聚乙二醇1000琥珀酸酯(TPGS)作为表面活性剂和固化剂的制剂。

结果

含10%和15% w/w FF的基于聚氧乙烯蓖麻油/聚乙二醇和TPGS的S-SEDDS制剂分散于水中时形成粒径范围为150 - 200 nm的纳米乳。制剂中FF以结晶状态存在。含10% w/w FF的制剂在60分钟内溶出度达90 - 100%,而未处理的FF溶出度仅为2 - 4%。

结论

使用聚氧乙烯蓖麻油/聚乙二醇和TPGS为FF开发了一种新型S-SEDDS。在模拟胃液pH 1.2条件下,FF的溶出度提高了约20倍。

相似文献

1
Solid self-emulsifying drug delivery system (S-SEDDS) for improved dissolution rate of fenofibrate.用于提高非诺贝特溶解速率的固体自乳化药物递送系统(S-SEDDS)
J Microencapsul. 2014;31(3):293-8. doi: 10.3109/02652048.2013.843601. Epub 2013 Oct 24.
2
Dissolution improvement of solid self-emulsifying drug delivery systems of fenofibrate using an inorganic high surface adsorption material.使用无机高表面吸附材料改善非诺贝特固体自乳化药物递送系统的溶出度
Acta Pharm. 2015 Mar;65(1):29-42. doi: 10.1515/acph-2015-0003.
3
Preparation and pharmaceutical evaluation of new tacrolimus-loaded solid self-emulsifying drug delivery system.新型载他克莫司固体自乳化药物递送系统的制备及药学评价
Arch Pharm Res. 2015 Feb;38(2):223-8. doi: 10.1007/s12272-014-0459-5. Epub 2014 Aug 20.
4
Comparison of in vitro tests at various levels of complexity for the prediction of in vivo performance of lipid-based formulations: case studies with fenofibrate.用于预测脂质体制剂体内性能的不同复杂程度体外试验的比较:非诺贝特的案例研究
Eur J Pharm Biopharm. 2014 Apr;86(3):427-37. doi: 10.1016/j.ejpb.2013.10.016. Epub 2013 Oct 31.
5
Enhancing in vitro dissolution and in vivo bioavailability of fenofibrate by solid self-emulsifying matrix combined with SBA-15 mesoporous silica.通过固体自乳化基质与SBA - 15介孔二氧化硅相结合提高非诺贝特的体外溶出度和体内生物利用度
Colloids Surf B Biointerfaces. 2016 May 1;141:476-482. doi: 10.1016/j.colsurfb.2016.02.013. Epub 2016 Feb 8.
6
Characterisation of fenofibrate dissolution delivered by a self-microemulsifying drug-delivery system.自微乳药物传递系统递送的非诺贝特溶出特性。
J Pharm Pharmacol. 2010 Dec;62(12):1685-96. doi: 10.1111/j.2042-7158.2010.01182.x. Epub 2010 Oct 5.
7
Formulation of spray congealed microparticles with self-emulsifying ability for enhanced glibenclamide dissolution performance.具有自乳化能力的喷雾冷凝微粒制剂用于增强格列本脲的溶解性能。
J Microencapsul. 2015;32(2):181-92. doi: 10.3109/02652048.2014.985341. Epub 2014 Nov 25.
8
Enhanced dissolution and oral absorption of tacrolimus by supersaturable self-emulsifying drug delivery system.他克莫司自乳化药物传递系统提高溶出度及口服吸收。
Int J Nanomedicine. 2016 Mar 18;11:1109-17. doi: 10.2147/IJN.S102991. eCollection 2016.
9
Development of solid self-emulsifying drug delivery system (SEDDS) I: use of poloxamer 188 as both solidifying and emulsifying agent for lipids.固体自乳化药物传递系统(SEDDS)的开发 I:泊洛沙姆 188 既作为固化剂又作为脂类的乳化剂的应用。
Pharm Res. 2012 Oct;29(10):2817-32. doi: 10.1007/s11095-012-0704-x. Epub 2012 Feb 28.
10
Design of fenofibrate microemulsion for improved bioavailability.设计用于提高生物利用度的非诺贝特微乳。
Int J Pharm. 2011 Nov 28;420(2):251-5. doi: 10.1016/j.ijpharm.2011.08.043. Epub 2011 Sep 3.

引用本文的文献

1
Preparation and Characterization of Fenofibrate-Loaded Fibers Based on 2-Hydroxylpropyl-β-Cyclodextrin.基于2-羟丙基-β-环糊精的非诺贝特载药纤维的制备与表征
Polymers (Basel). 2025 Apr 11;17(8):1037. doi: 10.3390/polym17081037.
2
Optimization of a Self-microemulsifying Drug Delivery System for Oral Administration of the Lipophilic Drug, Resveratrol: Enhanced Intestinal Permeability in Rat.用于口服亲脂性药物白藜芦醇的自微乳化药物递送系统的优化:大鼠肠道通透性增强
Adv Pharm Bull. 2023 Jul;13(3):521-531. doi: 10.34172/apb.2023.054. Epub 2022 Jul 2.
3
A Novel Semi-Solid Self-Emulsifying Formulation of Aprepitant for Oral Delivery: An In Vitro Evaluation.
一种用于口服给药的阿瑞匹坦新型半固体自乳化制剂:体外评价
Pharmaceutics. 2023 May 16;15(5):1509. doi: 10.3390/pharmaceutics15051509.
4
Preparation and Characterization of Fenofibrate-Loaded PVP Electrospun Microfibrous Sheets.非诺贝特负载的聚乙烯吡咯烷酮静电纺丝微纤维片的制备与表征
Pharmaceutics. 2020 Jun 30;12(7):612. doi: 10.3390/pharmaceutics12070612.
5
Lipid-based nanosystem of edaravone: development, optimization, characterization and in vitro/in vivo evaluation.依达拉奉脂质纳米系统:研发、优化、表征及体外/体内评价
Drug Deliv. 2017 Nov;24(1):962-978. doi: 10.1080/10717544.2017.1337825.